Clinical Experience with the Fraxel SR Laser: 202 Treatments in 59 Consecutive Patients

Cohen, Steven R.; Henssler, Cory; Horton, K.; Broder, Kevin; Moise-Broder, Pamela A.

doi:10.1097/prs.0b013e31816c3b65

Cited by 23 publications

(11 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, NAFL requires 3–6 monthly treatments in order to gain substantial improvement. A number of wavelengths have been evaluated for clinical improvement in photodamage and rhytides of the face, including 1,440 nm neodymium:yttrium aluminum garnet (Nd:YAG), 1,320/1,440 nm Nd:YAG, 1,540 nm erbium:glass, and 1,550 nm erbium‐doped fiber NAFL devices .…”

Section: Introductionmentioning

confidence: 99%

Treatment of facial photodamage and rhytides using a novel 1,565 nm non‐ablative fractional erbium‐doped fiber laser

et al. 2015

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Treatment of facial photodamage and rhytides using a novel 1,565 nm non‐ablative fractional erbium‐doped fiber laser

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Furthermore, the use of the 1,550 nm wavelength, which targets water as its main chromophore without significant absorption by melanin, reduces the risk of pigmentary disturbance especially in dark‐skinned patients. Earlier studies on NAFR, performed mostly in patients with lighter skin types, reported an overall PIH incidence ranging from 0 to less than 1% 14, 21–25. Graber et al retrospectively studied 961 treatments with the 1,550 nm erbium‐doped fibre laser and found no difference in side effects for different skin types, except for PIH.…”

Section: Discussionmentioning

confidence: 99%

The use of non‐ablative fractional resurfacing in Asian acne scar patients

Chan

Yeung

et al. 2010

Lasers Surg Med

View full text Add to dashboard Cite

show abstract

“…30 Successful outcomes in other studies of postsurgical scar treatment have been reported. 31,32 Beneficial results have been documented in hypopigmented surgical and poststeroid injection scars as well. 33 In one small study, 7 patients with long-standing hypopigmented scars were treated with a 1,550-nm nonablative fractional device up to four times, and all experienced significant subjective and objective improvement.…”

Section: Clinical Data For Acne and Surgical Scarringmentioning

confidence: 99%

11 Nonablative Laser and Light Devices

Truswell¹

2016

Lasers and Light, Peels and Abrasions

View full text Add to dashboard Cite

The development of laser and light therapy for skin resurfacing has revolutionized the treatment of photodamage, wrinkles, scars, and a variety of pigmented lesions. The earliest lasers used for this purpose were ablative and included carbon dioxide (CO 2 ) and erbium: yttrium aluminum garnet (Er:YAG) devices. Treatment with these ablative lasers results in coagulation and vaporization of the entire epidermal unit with the goal of improving the quality of treated skin. Downtime is in the range of 5 to 14 days, and over this period of time patients can experience edema, oozing, and discomfort. Erythema can last for months to years and dyspigmentation, including depigmentation, can appear at any time after treatment-including years later. These complications are of particular concern for patients of higher Fitzpatrick skin types, and limit the use of these lasers to Fitzpatrick types I through III. Infection and scarring can occur as well due to prolonged compromise of the epidermal barrier unit. Results are dramatic for reversal of photoaging, but the side-effect profile is a deterrent for some patients and physicians and has limited the use of fully ablative laser resurfacing. 1,2,3 Nonablative technologies were developed to allow for faster postprocedure skin recovery, targeting the deep dermis to remodel collagen. Although these lasers have the benefit of shorter downtime, more sessions are required to achieve results similar to the ablative lasers, often requiring five or six monthly treatments. These devices are also typically paired with a cooling tip that allows for cooling of the epidermis and selective treatment to the dermis. The damage induced by nonablative devices is by definition "not ablative" and does not result in disruption of the epidermis or vaporization of tissue. Characteristic histology includes coagulation of dermal components. The term nonablative is broad in nature, and can include any device that does not cause ablation. However, for true practical purposes, and for this chapter, the nonablative devices are those that are moderately absorbed by water with wavelengths ranging from 1,064 to 2,000 nm. Other devices, which deliver nonspecific thermal energy and are by definition nonablative such as radiofrequency and ultrasound technologies, are not discussed here. Nonablative Nonfractionated LasersThe 1,320-nm neodymium:yttrium aluminum garnet (Nd:YAG) laser (CoolTouch, ICN Pharmaceuticals, Costa Mesa, California) was the first exclusively nonablative laser developed. Energy penetration occurs to a depth of 1,600 µm, a potentially effective treatment depth. Safety was optimal, yet studies showed only minimal clinical improvement in rhytids and photoaging. 4,5,6 The Smoothbeam laser (Candela Corp., Wayland, Massachusetts) emits coherent light at 1,450 nm. This device also uses water as the chromophore and results in thermal injury to the dermis and dermal components. The epidermis is protected via dynamic cryogen cooling. In 2003, Tanzi et al reported a mild to moderate clinical improvement ...

show abstract

Clinical Experience with the Fraxel SR Laser: 202 Treatments in 59 Consecutive Patients

Abstract: This study reports the largest experience to date with the clinical use of the Fraxel SR laser and is the first report of patient satisfaction after fractional photothermolysis. Patients reported high satisfaction rates for improvements in texture, dyschromia, and scarring.

Cited by 23 publications

References 3 publications

Treatment of facial photodamage and rhytides using a novel 1,565 nm non‐ablative fractional erbium‐doped fiber laser

Treatment of facial photodamage and rhytides using a novel 1,565 nm non‐ablative fractional erbium‐doped fiber laser

The use of non‐ablative fractional resurfacing in Asian acne scar patients

11 Nonablative Laser and Light Devices

Contact Info

Product

Resources

About